Article info

Download PDFPDF

Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial

Authors

  1. Correspondence to Dr Eduardo L Franco; eduardo.franco{at}mcgill.ca
View Full Text

Citation

Ramanakumar AV, Naud P, Roteli-Martins CM for the HPV-007 Study Group, et al
Incidence and duration of type-specific human papillomavirus infection in high-risk HPV-naïve women: results from the control arm of a phase II HPV-16/18 vaccine trial

Publication history

  • Received February 1, 2016
  • Revised April 26, 2016
  • Accepted June 15, 2016
  • First published August 26, 2016.
Online issue publication 
August 26, 2016

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.